Stock Events

Stock Events

Guard Therapeutics International AB 

SEK1.03
1
+SEK0+0.39% Today

Statistics

Day High
1.03
Day Low
1
52W High
25.9
52W Low
0.95
Volume
187,667
Avg. Volume
-
Mkt Cap
20.73M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-192.13MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GUARD.ST. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.45B
Vertex Pharmaceuticals, involved in treating cystic fibrosis and other serious diseases, overlaps with Guard's focus on critical care.
AMGEN
AMGN
Mkt Cap185.74B
Amgen, a biotech firm working on innovative therapies including for kidney diseases, aligns with Guard's renal protection products.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.46B
Regeneron Pharmaceuticals, known for its innovative biopharmaceuticals, competes in the space of novel therapies for complex diseases.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.28B
BioMarin Pharmaceutical, specializes in enzyme replacement therapies, competing in the broader market of rare disease treatments.
Novo Nordisk
NVO
Mkt Cap182.6B
Novo Nordisk, with a strong presence in diabetes care, indirectly competes in the metabolic and endocrine areas relevant to kidney health.
Gilead Sciences
GILD
Mkt Cap161.85B
Gilead Sciences, a leader in antiviral drugs and other serious medical conditions, shares a focus on innovative, life-saving treatments.
Biogen
BIIB
Mkt Cap27.06B
Biogen, focuses on neurological and neurodegenerative diseases, competes in the high-stakes biotech space for groundbreaking therapies.
Astrazeneca
AZN
Mkt Cap294.17B
AstraZeneca, a global biopharmaceutical company, has a diverse portfolio that includes treatments for kidney-related conditions.
Pfizer
PFE
Mkt Cap153.59B
Pfizer, one of the largest pharmaceutical companies, competes across various therapeutic areas including those relevant to Guard's interests.

About

Guard Therapeutics International AB (publ), a clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden. The company's pipeline products include RMC-035, an intact therapeutic A1M protein, that is in Phase 2b clinical trial for kidney protection with open-heart surgery; in Phase 2a clinical trial for kidney transplantation; and is in preclinical trial to treat Sepsis. It also develops GTZ peptides, a modified A1M-derived peptides which is in preclinical studies for the treatment of CKD and diabetes, heart failure, alport syndrome, sickle-cell nephropathy, and preeclampsia. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
Show more...
CEO
Mr. Tobias Larsson Agervald
Employees
12
Country
Sweden
ISIN
SE0021181559

Listings

MU
DE
5LH0.MU
F
DE
5LH0.F
ST
SE
GUARD.ST

0 Comments

Share your thoughts

FAQ

What is Guard Therapeutics International AB stock price today?▼
The current price of GUARD.ST is SEK1.03 SEK — it has increased by +0.39% in the past 24 hours. Watch Guard Therapeutics International AB stock price performance more closely on the chart.
What is Guard Therapeutics International AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Guard Therapeutics International AB stocks are traded under the ticker GUARD.ST.
Is Guard Therapeutics International AB stock price growing?▼
GUARD.ST stock has risen by +7.98% compared to the previous week, the month change is a -30.31% fall, over the last year Guard Therapeutics International AB has showed a -92.18% decrease.
What is Guard Therapeutics International AB market cap?▼
Today Guard Therapeutics International AB has the market capitalization of 20.73M
When is the next Guard Therapeutics International AB earnings date?▼
Guard Therapeutics International AB is going to release the next earnings report on May 13, 2026.
What is Guard Therapeutics International AB revenue for the last year?▼
Guard Therapeutics International AB revenue for the last year amounts to 0 SEK.
What is Guard Therapeutics International AB net income for the last year?▼
GUARD.ST net income for the last year is -192.13M SEK.
How many employees does Guard Therapeutics International AB have?▼
As of April 29, 2026, the company has 12 employees.
In which sector is Guard Therapeutics International AB located?▼
Guard Therapeutics International AB operates in the Health & Wellness sector.
When did Guard Therapeutics International AB complete a stock split?▼
The last stock split for Guard Therapeutics International AB was on December 15, 2023 with a ratio of 1:50.
Where is Guard Therapeutics International AB headquartered?▼
Guard Therapeutics International AB is headquartered in Stockholm, Sweden.